Optiver Holding
ALNY icon

Optiver Holding’s Alnylam Pharmaceuticals ALNY Stock Holding History

Optiver Holding’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3K Buy
+64
New +$19.3K ﹤0.01% 1535
2023
Q2 		– Sell
-2
Closed -$401 – 483
2023
Q1 		$401 Sell
2
-9
-82% -$1.89K ﹤0.01% 504
2022
Q4 		$3K Buy
+11
New +$2.35K ﹤0.01% 414
2022
Q1 		– Sell
-124
Closed -$21K – 510
2021
Q4 		$21K Buy
+124
New +$23K ﹤0.01% 565

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Optiver Holding's ALNY Position: Q2 2026 in Review

Optiver Holding opened a new position in Alnylam Pharmaceuticals (ALNY) in Q2 2026: 64 shares worth $19.3K. The stake represents ﹤0.01% of the portfolio and ranks #1535 among its holdings. This is a return to the name: Optiver Holding previously reported a position in ALNY as recently as Q1 2023.

Optiver Holding first reported a position in ALNY in Q4 2021 and has held it in 4 quarters since. The position peaked at $21K in Q4 2021. 791 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Optiver Holding held 64 shares of Alnylam Pharmaceuticals worth $19.3K as of Q2 2026.
  • Alnylam Pharmaceuticals was a new Optiver Holding position in Q2 2026.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1535 holding.
  • Optiver Holding first reported a position in Alnylam Pharmaceuticals in Q4 2021 and has held it in 4 quarters since.
  • Optiver Holding's Alnylam Pharmaceuticals position peaked at $21K in Q4 2021.
  • 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.